Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.970
-0.130 (-6.19%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $73.74 million as of October 31, 2024.
Market Cap
73.74M
Enterprise Value
-173.38M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $73.74M, a decrease of -86.90%. That is a compound annual growth rate of -93.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 78.60M | -86.04% |
Feb 9, 2024 | 562.92M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CytomX Therapeutics | 78.04M |
Xtant Medical Holdings | 77.68M |
Monogram Technologies | 76.40M |
Rani Therapeutics Holdings | 75.56M |
ALX Oncology Holdings | 73.74M |
Cellectar Biosciences | 73.49M |
Modular Medical | 73.26M |
Adlai Nortye | 72.69M |